Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

作者
Fabienne Guillaumond,Ghislain Bidaut,Mehdi Ouaïssi,Stéphane Servais,Victoire Gouirand,Orianne Olivares,Sophie Lac,Laurence Borge,Julie Roques,Odile Gayet,Michelle Pinault,Cyrille Guimaraes,Jérémy Nigri,Céline Loncle,Marie‐Noëlle Lavaut,Stéphane Garcia,Anne Tailleux,Bart Staels,Ezequiel Luis Calvo,Richard Tomasini
出处
期刊:Proceedings of the National Academy of Sciences of the United States of America [National Academy of Sciences]
卷期号:112 (8): 2473-2478 被引量:449
标识
DOI:10.1073/pnas.1421601112
摘要

The malignant progression of pancreatic ductal adenocarcinoma (PDAC) is accompanied by a profound desmoplasia, which forces proliferating tumor cells to metabolically adapt to this new microenvironment. We established the PDAC metabolic signature to highlight the main activated tumor metabolic pathways. Comparative transcriptomic analysis identified lipid-related metabolic pathways as being the most highly enriched in PDAC, compared with a normal pancreas. Our study revealed that lipoprotein metabolic processes, in particular cholesterol uptake, are drastically activated in the tumor. This process results in an increase in the amount of cholesterol and an overexpression of the low-density lipoprotein receptor (LDLR) in pancreatic tumor cells. These findings identify LDLR as a novel metabolic target to limit PDAC progression. Here, we demonstrate that shRNA silencing of LDLR, in pancreatic tumor cells, profoundly reduces uptake of cholesterol and alters its distribution, decreases tumor cell proliferation, and limits activation of ERK1/2 survival pathway. Moreover, blocking cholesterol uptake sensitizes cells to chemotherapeutic drugs and potentiates the effect of chemotherapy on PDAC regression. Clinically, high PDAC Ldlr expression is not restricted to a specific tumor stage but is correlated to a higher risk of disease recurrence. This study provides a precise overview of lipid metabolic pathways that are disturbed in PDAC. We also highlight the high dependence of pancreatic cancer cells upon cholesterol uptake, and identify LDLR as a promising metabolic target for combined therapy, to limit PDAC progression and disease patient relapse.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
wyp发布了新的文献求助10
刚刚
1秒前
浚稚完成签到 ,获得积分0
1秒前
1秒前
十三发布了新的文献求助10
2秒前
zhikaiyici发布了新的文献求助30
2秒前
完美世界的应助被嘟嘟采纳,获得10
2秒前
JamesPei的应助被清辉影采纳,获得10
2秒前
木槿花开完成签到 ,获得积分10
3秒前
mingzhi发布了新的文献求助10
3秒前
cdercder的应助被晚风采纳,获得10
3秒前
stone发布了新的文献求助10
3秒前
诗和远方完成签到 ,获得积分10
4秒前
4秒前
4秒前
4秒前
4秒前
杨JY发布了新的文献求助10
5秒前
烂漫过客发布了新的文献求助10
5秒前
277发布了新的文献求助10
5秒前
6秒前
6秒前
ssjsrtjgh完成签到,获得积分10
6秒前
6秒前
贎幸完成签到,获得积分10
7秒前
Rolly发布了新的文献求助10
7秒前
7秒前
钟梓袄发布了新的文献求助10
7秒前
乐空思的应助被旌淰采纳,获得20
7秒前
8秒前
平淡若云完成签到,获得积分10
8秒前
LL发布了新的文献求助10
8秒前
CHL5722完成签到,获得积分10
8秒前
8秒前
9秒前
Lu发布了新的文献求助10
9秒前
赘婿的应助被哈哈哈哈采纳,获得10
10秒前
10秒前
Lucas的应助被Y1212采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148